Deconsal C Expectorant Interactions
There are 625 drugs known to interact with Deconsal C Expectorant (codeine / guaifenesin / pseudoephedrine), along with 22 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 129 are major, 491 are moderate, and 5 are minor.
- View all 625 medications that may interact with Deconsal C Expectorant
- View Deconsal C Expectorant alcohol/food interactions (2)
- View Deconsal C Expectorant disease interactions (22)
Most frequently checked interactions
View interaction reports for Deconsal C Expectorant (codeine / guaifenesin / pseudoephedrine) and the medicines listed below.
- Amaryl (glimepiride)
- Aranesp (darbepoetin alfa)
- Cipro (ciprofloxacin)
- Coreg (carvedilol)
- Digitek (digoxin)
- ferrous gluconate
- gabapentin
- Humalog (insulin lispro)
- Lantus (insulin glargine)
- Lasix (furosemide)
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- lisinopril
- omeprazole
- potassium bicarbonate / potassium citrate
- TriCor (fenofibrate)
- Vitamin B12 (cyanocobalamin)
- Vitamin D2 (ergocalciferol)
Deconsal C Expectorant alcohol/food interactions
There are 2 alcohol/food interactions with Deconsal C Expectorant (codeine / guaifenesin / pseudoephedrine).
Deconsal C Expectorant disease interactions
There are 22 disease interactions with Deconsal C Expectorant (codeine / guaifenesin / pseudoephedrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
More about Deconsal C Expectorant (codeine / guaifenesin / pseudoephedrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.